Vertaling van "effect of carvedilol in patients with severe " (Frans → Nederlands) :

systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study.
16. Rouleau J, Roecker E, Tendera M et al. Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study.

Depuis lors, des données sur l’usage de β-bloquants chez des patients présentant une insuffisance cardiaque stable sévère, accompagnée d’un dysfonctionnement systolique ventriculaire gauche, sont disponibles: une diminution de la mortalité et du risque d’hospitalisation a ainsi été constatée à ce sujet avec le carvédilol, mais pas avec le bucindolol.
Sedertdien zijn gegevens beschikbaar gekomen over gebruik van β-blokkers bij patiënten met stabiel, ernstig hartfalen met systolische linkerventrikeldisfunctie: met carvedilol, maar niet met bucindolol, werd daarbij een daling van de mortaliteit en van het risico van hospitalisatie gezien.

For primary prevention of stroke, adequate blood pressure reduction, and treatment of hyperlipidemia, use of antithrombotic therapy in patients with atrial fibrillation and of antiplatelet therapy in patients with myocardial infarction are effective and supported by evidence from several
For primary prevention of stroke, adequate blood pressure reduction, and treatment of hyperlipidemia, use of antithrombotic therapy in patients with atrial fibrillation and of antiplatelet therapy in patients with myocardial infarction are effective and supported by evidence from several randomized trials.1 Effective strategies for the secondary prevention of stroke include

Aliment Pharamcol Ther 2009; 29:55-68. van Marrewijk C, Mujakovic S, Fransen G et al. Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): primary-care-based randomised controlled trial.
Aliment Pharamcol Ther 2009; 29:55-68. Numans ME, de Wit NJ, Dirven JAM et al. NHG Standaard Maagklachten, tweede herziening.

randomized trials.1 Effective strategies for the secondary prevention of stroke include treatment of hypertension and hyperlipidemia, antithrombotic therapy for patients with atrial fibrillation, and antiplatelet therapy (Evidence level 1). 1 Statins are effective in the prevention of stroke, although evidence remains limited to heart disease patients (Evidence level 1). 2, 3
treatment of hypertension and hyperlipidemia, antithrombotic therapy for patients with atrial fibrillation, and antiplatelet therapy (Evidence level 1).1 Statins are effective in the prevention of stroke, although evidence remains limited to heart disease patients (Evidence level 1).2, 3

27. Mas JL, Chatellier G, Beyssen B. Carotid angioplasty and stenting with and without cerebral protection: clinical alert from the Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis (EVA-3S) trial.
cerebral protection: clinical alert from the Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis (EVA-3S) trial.

Pour les patients présentant une fatigue chronique depuis très longtemps (5 ans en moyenne) et souvent sévère (notamment sur le plan physique), l’objectif poursuivi est peut-être trop ambitieux pour une amélioration significative du fonctionnement socioprofessionnel, sur la base d’un programme de rééducation fonctionnelle limité quant à la durée de traitement effective.
Bij patiënten die al zeer lang chronisch vermoeid zijn (gemiddeld 5 jaar) en vaak ernstig (onder meer fysiek) geïnvalideerd zijn door hun klachten, is de doelstelling mogelijk te hoog gegrepen om het socioprofessioneel functioneren significant te verbeteren, op basis van een qua effectieve behandelingsduur beperkt revalidatieprogramma.

12. Campillo B, Dupeyron C et al : Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis
12. Campillo B, Dupeyron C et al: Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis

12. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis.
of carotid endarterectomy in patients with symptomatic moderate or severe stenosis.

Search Date July 2007. [http ...]
Kaltenbach T, Crockett S, Gerson L. Are lifestyle measures effective in patients with gastroesophagal reflux disease?